# Multiomics Integration of Parkinson’s Disease Datasets Reveals Unexpected Roles of IRE1 in Its Pathology

**Authors:** Bianka Alexandra Pasat, Matthieu Moncan, Eleftherios Pilalis, Afshin Samali, Aristotelis Chatziioannou, Adrienne M. Gorman

PMC · DOI: 10.3390/ijms26146711 · International Journal of Molecular Sciences · 2025-07-12

## TL;DR

This study finds that IRE1 signaling through RIDD plays a role in Parkinson’s disease pathology, linking alternative splicing events to immune and stress responses.

## Contribution

The study reveals novel roles of IRE1 and RIDD in Parkinson’s disease through multiomics integration.

## Key findings

- IRE1 is active in Parkinson’s disease samples and influences alternative splicing via RIDD.
- OSBPL3, C16orf74, and SLC6A1 mRNAs are targets of IRE1 RNAse activity.
- RIDD targets are associated with immune response, oxidative stress, and cell communication in PD.

## Abstract

Parkinson’s disease (PD) is the second most common neurodegenerative disease. It primarily affects the motor system but is also associated with a range of cognitive impairments that can manifest early in disease progression, indicating its multifaceted nature. In this paper, we performed a meta-analysis of transcriptomics and proteomics data using MultiOmicsIntegrator to gain insights into the post-transcriptional modifications and deregulated pathways associated with this disease. Our results reveal differential isoform usage between control and PD patient brain samples that result in enriched alternative splicing events, including an extended UTR length, domain loss, and the upregulation of non-coding isoforms. We found that Inositol-Requiring Enzyme 1 (IRE1) is active in PD samples and examined the role of its downstream signaling through X-box binding mRNA 1 (XBP1) and regulated IRE1-dependent decay (RIDD). We identified several RIDD candidates and showed that the enriched alternative splicing events observed are associated with RIDD. Moreover, in vitro mRNA cleavage assays demonstrated that OSBPL3, C16orf74, and SLC6A1 mRNAs are targets of IRE1 RNAse activity. Finally, a pathway enrichment analysis of both XBP1s and RIDD targets in the PD samples uncovered associations with processes such as immune response, oxidative stress, signal transduction, and cell–cell communication that have previously been linked to PD. These findings highlight a potential regulatory role of IRE in PD.

## Linked entities

- **Genes:** ERN1 (endoplasmic reticulum to nucleus signaling 1) [NCBI Gene 2081], XBP1 (X-box binding protein 1) [NCBI Gene 7494], OSBPL3 (oxysterol binding protein like 3) [NCBI Gene 26031], CLMB (calcimembrin) [NCBI Gene 404550], SLC6A1 (solute carrier family 6 member 1) [NCBI Gene 6529]
- **Diseases:** Parkinson’s disease (MONDO:0005180)

## Full-text entities

- **Genes:** XBP1 (X-box binding protein 1) [NCBI Gene 7494] {aka TREB-5, TREB5, XBP-1, XBP2}, OSBPL3 (oxysterol binding protein like 3) [NCBI Gene 26031] {aka ORP-3, ORP3, OSBP3}, CLMB (calcimembrin) [NCBI Gene 404550] {aka ASRA, C16orf74, MICT1}, ERN1 (endoplasmic reticulum to nucleus signaling 1) [NCBI Gene 2081] {aka IRE1, IRE1P, IRE1a, hIRE1p}, SLC6A1 (solute carrier family 6 member 1) [NCBI Gene 6529] {aka GABATHG, GABATR, GAT1, MAE, hGAT-1}
- **Diseases:** cognitive impairments (MESH:D003072), PD (MESH:D010300), neurodegenerative disease (MESH:D019636)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12295087/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12295087/full.md

## References

48 references — full list in the complete paper: https://tomesphere.com/paper/PMC12295087/full.md

---
Source: https://tomesphere.com/paper/PMC12295087